283 related articles for article (PubMed ID: 11238683)
41. Genomic profiling of the genes on chromosome 3p in sporadic clear cell renal cell carcinoma.
Togo Y; Yoshikawa Y; Suzuki T; Nakano Y; Kanematsu A; Zozumi M; Nojima M; Hirota S; Yamamoto S; Hashimoto-Tamaoki T
Int J Oncol; 2016 Apr; 48(4):1571-80. PubMed ID: 26891804
[TBL] [Abstract][Full Text] [Related]
42. Chromosome 3 translocations and the risk to develop renal cell cancer: a Dutch intergroup study.
Van Erp F; Van Ravenswaaij C; Bodmer D; Eleveld M; Hoogerbrugge N; Mulders P; Geurts van Kessel A
Genet Couns; 2003; 14(2):149-54. PubMed ID: 12872808
[TBL] [Abstract][Full Text] [Related]
43. Vascular endothelial growth factor overexpression is correlated with von Hippel-Lindau tumor suppressor gene inactivation in patients with sporadic renal cell carcinoma.
Igarashi H; Esumi M; Ishida H; Okada K
Cancer; 2002 Jul; 95(1):47-53. PubMed ID: 12115316
[TBL] [Abstract][Full Text] [Related]
44. A constitutional balanced t(3;8)(p14;q24.1) translocation results in disruption of the TRC8 gene and predisposition to clear cell renal cell carcinoma.
Poland KS; Azim M; Folsom M; Goldfarb R; Naeem R; Korch C; Drabkin HA; Gemmill RM; Plon SE
Genes Chromosomes Cancer; 2007 Sep; 46(9):805-12. PubMed ID: 17539022
[TBL] [Abstract][Full Text] [Related]
45. Mutational analysis of endothelial cells derived from von Hippel-Lindau-related renal cancer.
Los M; Kerckhaert OA; Zewald R; van Amstel HK; Voest EE
J Natl Cancer Inst; 2000 Oct; 92(20):1688-9. PubMed ID: 11036115
[No Abstract] [Full Text] [Related]
46. Analysis of multiple renal cell adenomas and carcinomas suggests allelic loss at 3p21 to be a prerequisite for malignant development.
van den Berg A; Dijkhuizen T; Draaijers TG; Hulsbeek MM; Maher ER; van den Berg E; Störkel S; Buys CH
Genes Chromosomes Cancer; 1997 Aug; 19(4):228-32. PubMed ID: 9258657
[TBL] [Abstract][Full Text] [Related]
47. Malignant papillary renal tumors with extensive clear cell change: a molecular analysis by microsatellite analysis and fluorescence in situ hybridization.
Salama ME; Worsham MJ; DePeralta-Venturina M
Arch Pathol Lab Med; 2003 Sep; 127(9):1176-81. PubMed ID: 12946227
[TBL] [Abstract][Full Text] [Related]
48. An alternative route for multistep tumorigenesis in a novel case of hereditary renal cell cancer and a t(2;3)(q35;q21) chromosome translocation.
Bodmer D; Eleveld MJ; Ligtenberg MJ; Weterman MA; Janssen BA; Smeets DF; de Wit PE; van den Berg A; van den Berg E; Koolen MI; Geurts van Kessel A
Am J Hum Genet; 1998 Jun; 62(6):1475-83. PubMed ID: 9585616
[TBL] [Abstract][Full Text] [Related]
49. High frequency loss of heterozygosity in von Hippel-Lindau (VHL)-associated and sporadic pancreatic islet cell tumors: evidence for a stepwise mechanism for malignant conversion in VHL tumorigenesis.
Lott ST; Chandler DS; Curley SA; Foster CJ; El-Naggar A; Frazier M; Strong LC; Lovell M; Killary AM
Cancer Res; 2002 Apr; 62(7):1952-5. PubMed ID: 11929809
[TBL] [Abstract][Full Text] [Related]
50. Clear-cell and papillary carcinoma of the kidney: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification, cytogenetics, and fluorescence in situ hybridization.
Hughson MD; Dickman K; Bigler SA; Meloni AM; Sandberg AA
Cancer Genet Cytogenet; 1998 Oct; 106(2):93-104. PubMed ID: 9797772
[TBL] [Abstract][Full Text] [Related]
51. VHL gene alterations in renal cell carcinoma patients: novel hotspot or founder mutations and linkage disequilibrium.
Ma X; Yang K; Lindblad P; Egevad L; Hemminki K
Oncogene; 2001 Aug; 20(38):5393-400. PubMed ID: 11536052
[TBL] [Abstract][Full Text] [Related]
52. Molecular analysis of a familial case of renal cell cancer and a t(3;6)(q12;q15).
Eleveld MJ; Bodmer D; Merkx G; Siepman A; Sprenger SH; Weterman MA; Ligtenberg MJ; Kamp J; Stapper W; Jeuken JW; Smeets D; Smits A; Geurts Van Kessel A
Genes Chromosomes Cancer; 2001 May; 31(1):23-32. PubMed ID: 11284032
[TBL] [Abstract][Full Text] [Related]
53. Familial non-syndromic clear cell renal cell carcinoma.
Woodward ER
Curr Mol Med; 2004 Dec; 4(8):843-8. PubMed ID: 15579031
[TBL] [Abstract][Full Text] [Related]
54. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas.
Na X; Wu G; Ryan CK; Schoen SR; di'Santagnese PA; Messing EM
J Urol; 2003 Aug; 170(2 Pt 1):588-92. PubMed ID: 12853836
[TBL] [Abstract][Full Text] [Related]
55. Analysis of aberrant methylation of the VHL gene by transgenes, monochromosome transfer, and cell fusion.
Kuzmin I; Geil L; Ge H; Bengtsson U; Duh FM; Stanbridge EJ; Lerman MI
Oncogene; 1999 Oct; 18(41):5672-9. PubMed ID: 10523847
[TBL] [Abstract][Full Text] [Related]
56. [Prevention of renal carcinoma: the nutri-genetic approach].
Junien C; Dupret JM; Gallou C; Longuemaux S; Richard S; Saquet C; Krishnamoorty R; Delomenie C; Droz D; Bouvier R; Chauveau D; Joly D; Grunfeld JP; Chretien Y; Mejean A; Beroud C
J Soc Biol; 2000; 194(1):29-38. PubMed ID: 11107547
[TBL] [Abstract][Full Text] [Related]
57. Detection of loss of heterozygosity at chromosome 3p25-26 in primary and metastatic ovarian clear-cell carcinoma: utilization of microdissection and polymerase chain reaction in archival tissues.
Simsir A; Palacios D; Linehan WM; Merino MJ; Abati A
Diagn Cytopathol; 2001 May; 24(5):328-32. PubMed ID: 11335962
[TBL] [Abstract][Full Text] [Related]
58. Detection of circulating cancer cells with von hippel-lindau gene mutation in peripheral blood of patients with renal cell carcinoma.
Ashida S; Okuda H; Chikazawa M; Tanimura M; Sugita O; Yamamoto Y; Nakamura S; Moriyama M; Shuin T
Clin Cancer Res; 2000 Oct; 6(10):3817-22. PubMed ID: 11051223
[TBL] [Abstract][Full Text] [Related]
59. Mutations of the VHL tumour suppressor gene in renal carcinoma.
Gnarra JR; Tory K; Weng Y; Schmidt L; Wei MH; Li H; Latif F; Liu S; Chen F; Duh FM
Nat Genet; 1994 May; 7(1):85-90. PubMed ID: 7915601
[TBL] [Abstract][Full Text] [Related]
60. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
